Dr. Anand Tandra, MD

Dr. Tandra practices at Franciscan Health Indianapolis in Indianapolis, Indiana, part of Franciscan Alliance.

Dr. Tandra's NPI, 1649495854, was assigned on April 13, 2007. Dr. Tandra holds Indiana license 01063029A.

Dr. Tandra's primary practice is Franciscan Health Indianapolis, at 8111 S Emerson Ave, Indianapolis, IN 46237 in Marion County. The practice phone is (317) 528-5000.

Dr. Tandra's primary practice is Franciscan Health Indianapolis in Indianapolis, Indiana, part of Franciscan Alliance. Dr. Tandra is also affiliated with Hendricks Regional Health Danville Hospital. The medical group on file is Community Physician Network. Dmand AI also links Dr. Tandra to 4 more hospitals and 6 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Tandra practices, 6 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Tandra's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Tandra is licensed in Indiana.

CMS data shows 1,054 Medicare services from Dr. Tandra across 10 procedure codes in 2024, for 185 Medicare patients. Medicare paid $83,171 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 185 Medicare patients who saw Dr. Tandra in 2024. The largest group is 65 to 74, with 117 patients. 75% of them have high blood pressure, and 64% have high cholesterol. 11% are also on Medicaid. Their average risk score is 3.10, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Tandra's median patient age at 69, with 43% women.

In 2024, Dr. Tandra wrote 936 Medicare Part D claims for 154 patients. 80% of them were for generic drugs. CMS names the drug for 569 of them, across 23 drugs with 11 or more claims each, at $482,002 in total drug cost. In 2023, CMS named 102 claims across 5 drugs.

Dr. Tandra accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Tandra as offering telehealth.

Dmand AI links 7 papers to Dr. Tandra, published from 2014 to 2025. 2014 was the busiest year, with 2. The most frequent topics are Anticoagulants, Mesenteric Veins and Morpholines. Dr. Tandra has published most often in Hepatology. Dr. Tandra's most frequent co-authors are Carl E. Allen, MD, Edward Malachi Behrens, MD and Deepika Bhatla, MD.

Dmand AI links Dr. Tandra to 4 clinical trials, 3 of them phase 2 studies. 1 is still active or recruiting. Conditions studied include Leukemia, Myeloid, Acute, Leukemia, Myeloid and Leukemia, Myelomonocytic, Chronic.

CMS Open Payments shows 497 general payments to Dr. Tandra from 50 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 75% of the total. Kite Pharma, Inc. paid the most, $110,100. It also lists 3 research payments totaling $825 from 2022 to 2023.